Fiche publication
Date publication
juin 2025
Journal
Brachytherapy
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier
,
Dr DEMOGEOT Nadine
,
Dr MARTZ Nicolas
Tous les auteurs :
Renard S, Meknaci E, Cuisinier C, Perrin-Lhuillier J, Lemoine L, Bruand M, Charra-Brunaud C, Py JF, Demogeot N, Martz N, Buchheit I, Marchesi V, Peiffert D
Lien Pubmed
Résumé
In February 2021, the Brachytherapy department of the Lorraine Cancer Institute began a transition away from pulsed dose rate (PDR) towards high dose rate (HDR) brachytherapy, for gynaecological cancer, cancers of the oral cavity, oropharynx and anal canal, penile cancer and sarcoma. We describe our experience here; for the benefit of other brachytherapy departments that may be envisaging a similar transition in care.
Mots clés
Brachytherapy, HDR, PDR
Référence
Brachytherapy. 2025 06 20;:
